Moderna on $1.3bn manufacturing scale-up of mRNA COVID vaccine
Moderna is confident of attaining 500 million doses of its COVID-19 vaccine candidate after using proceeds from a stock offering to scale-up manufacturing at its site in Massachusetts and at CDMO Lonza. In May, Moderna Therapeutics raised $1.3 billion through the sale of shares. According to the ...
Taking calculated risks will accelerate SARS-CoV-2 vaccine development according to CEPI, which says traditional techniques are too slow.
Deve ...
A robust quarter included a ramp-up in COVID-19-related orders, something Repligen says will set the scene for increased revenues in the second h ...
AbbVie has ended its Alzheimer’s and Parkinson’s disease collaborations with Voyager Therapeutics.
Voyager announced the termination of it ...
Eli Lilly is testing several antibodies in its efforts against COVID-19 but says a monotherapy, if successful, would help optimize manufacturing. ...
Recent Tweets
-
RT @Dan5tanton: Moderna is confident of attaining 500 million doses of its COVID-19 vaccine candidate after using proceeds from a s… https://t.co/sJrPuWgw69
2 days ago
-
RT @Dan5tanton: Manufacturing for #COVID19 vaccine to go to ‘Warp Speed’ https://t.co/kRYuE3Zi4H https://t.co/k1yY3wMweb
1 month ago
-
RT @Dan5tanton: Pharma Partnering: Perspectives from Xcelerating Life Sciences Panel https://t.co/TSX4cQrh3j via @xconomy
2 months ago
-
RT @Dan5tanton: Poll responses from @Xconomy #XconPHL
How likely is it that viral vectors will remain the standard vehicle for th… https://t.co/Hj10ZT6vui
2 months ago
Trending
Cell Therapy
Accelerate Cell and Gene Therapy Development and Manufacturing with Fully Integrated Closed CAR-T Cell Therapy Platform
Upstream Processing
eBook: Expression Systems — Innovative Techniques for Conventional Cell Lines
Ask the Experts
Figure Out Any Particle with Automated Counting, Sizing, Morphology, and Identification Using the Hound